🇰🇷 Fluorodopa F18 in South Korea

Fluorodopa F18 (fluorodopa (18F)) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Fluorodopa F18 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in South Korea

Frequently asked questions

Is Fluorodopa F18 approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Fluorodopa F18 in South Korea?

Feinstein is the originator. The local marketing authorisation holder may differ — check the official source linked above.